Benit Maru

Chief Medical Officer, Head of Clinical Development, Taysha Gene Therapy MB ChB, MSc (Neuroscience), MSc (Health Economics)

About this speaker

An academic physician, neuroimmunologist and health economist with extensive global experience in clinical research and development, translational medicine, health economics, real-world evidence, and medical affairs. His scientific and industry career has focused on neurology, neuroimmunology, immuno/haemato-oncology, and biological therapies for inflammatory diseases, nephrology, dermatology and rheumatology, and rare/ultra-rare disease.  His career has also focused on health economic modelling and real-world evidence generation for the above areas as well as close collaboration with market access representatives. Extensive gene therapy experience including supporting the development and commercialisation of a gene therapy for SMA.

Talks

Taysha Update: An Investigational Approach to Gene Therapy for Rett Syndrome (English)

17 March 2023, 01:00 PM
Benit Maru

Taysha Update: An Investigational Approach to Gene Therapy for Rett Syndrome (Hungarian)

17 March 2023, 01:00 PM
Benit Maru

Taysha Update: An Investigational Approach to Gene Therapy for Rett Syndrome (Dutch)

17 March 2023, 01:00 PM
Benit Maru

Taysha Update: An Investigational Approach to Gene Therapy for Rett Syndrome (Serbian)

17 March 2023, 01:00 PM
Benit Maru

Taysha Update: An Investigational Approach to Gene Therapy for Rett Syndrome (Georgian)

17 March 2023, 01:00 PM
Benit Maru

Taysha Update: An Investigational Approach to Gene Therapy for Rett Syndrome (Croatian)

17 March 2023, 01:00 PM
Benit Maru

Taysha Update: An Investigational Approach to Gene Therapy for Rett Syndrome (Turkish)

17 March 2023, 01:00 PM
Benit Maru